North East and North Cumbria
ICS Formulary
ICS Formulary
15 Anaesthesia
15-01-04-02 Non-opioid analgesics
| Diclofenac 75mg/1ml injection |
|
Formulary
|
|
 MHRA Drug Safety Update (June 2013): Diclofenac: new contraindications and warnings MHRA Drug Safety Update (June 2023): Non-steroidal anti-inflammatory drugs (NSAIDs): potential risks following prolonged use after 20 weeks of pregnancy |
|
| Ketorolac injection |
|
Formulary
|
|
|
|
Links
Guidelines for the Management of Adults with Asymptomatic Liver Blood Test Abnormalities- MHRA Drug Safety Update (June 2013): Diclofenac: new contraindications and warnings
- MHRA Drug Safety Update (June 2023): Non-steroidal anti-inflammatory drugs (NSAIDs): potential risks following prolonged use after 20 weeks of pregnancy
- NTAG: Transanal irrigation (TAI) systems (Peristeen Plus®, Aquaflush®, and QuFora®) for neurogenic bowel dysfunction, chronic constipation and chronic faecal incontinence